The contribution of Hind III C>G PAI-1 gene polymorphism in etiology of recurrent miscarriages.
暂无分享,去创建一个
[1] A. Bogacz,et al. The -323P0/P10 factor VII gene polymorphism and the risk of recurrent miscarriage. , 2014, Ginekologia polska.
[2] S. Tufik,et al. Saturated Fatty Acid Intake Can Influence Increase in Plasminogen Activator Inhibitor-1 in Obese Adolescents , 2014, Hormone and Metabolic Research.
[3] A. Seremak-Mrozikiewicz,et al. [The 20210G>A and 19911A>G polymorphisms of prothrombin gene and recurrent miscarriages]. , 2013, Ginekologia polska.
[4] R. Touraine,et al. Plasminogen Activator Inhibitor 1 4G/5G and −844G/A Variants in Idiopathic Recurrent Pregnancy Loss , 2013, American journal of reproductive immunology.
[5] Bo Eun Lee,et al. Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women , 2013, Thrombosis and Haemostasis.
[6] W. McGuire,et al. Association of Plasminogen Activator Inhibitor-Type 1 (-675 4G/5G) Polymorphism with Pre-Eclampsia: Systematic Review , 2013, PloS one.
[7] H. Zeraati,et al. Combination of Thrombophilic Gene Polymorphisms as a Cause of Increased the Risk of Recurrent Pregnancy Loss , 2012, Journal of reproduction & infertility.
[8] B. Illades-Aguiar,et al. Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children , 2012, BMC Pediatrics.
[9] H. Rangel-Villalobos,et al. Plasminogen activator inhibitor-1 polymorphisms (−844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables , 2011, Clinical and Experimental Medicine.
[10] O. Christiansen,et al. Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications. , 2010, Human reproduction.
[11] H. Rangel-Villalobos,et al. Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis , 2009, Clinical and Experimental Medicine.
[12] O. McGuinness,et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. , 2004, Diabetes.
[13] L. Pereira-leite,et al. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre‐eclampsia: correlation with proteinuria , 2002, BJOG : an international journal of obstetrics and gynaecology.
[14] J. Kooner,et al. Association of Maternal Endothelial Dysfunction With Preeclampsia , 2001 .
[15] C. Glueck,et al. Genetic Hypofibrinolysis in Complicated Pregnancies , 2001, Obstetrics and gynecology.
[16] T. Arinami,et al. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia , 2000, Journal of Human Genetics.
[17] H. Grenett,et al. Identification of the Hind III polymorphic site in the PAI-1 gene: analysis of the PAI-1 Hind III polymorphism by PCR. , 2000, Genetic testing.
[18] A. Henney,et al. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.